Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stereotactic radiotherapy combined with erlotinib for brain metastases from lung cancer
ChiCTR1900027546Phase 4Not yet recruiting
- Sponsor
- Liaoning Province Cancer Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of erlotinib in bronchial carcinoma (2 arms), sponsored by Liaoning Province Cancer Hospital. Primary endpoint: overall survival. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
erlotinib
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR1900027546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027546.